Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

8.45
Delayed Data
As of Sep 03
 -0.79 / -8.55%
Today’s Change
6.23
Today|||52-Week Range
25.60
-47.32%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close9.24
Today’s open9.19
Day’s range8.41 - 9.35
Volume899,061
Average volume (3 months)805,481
Market cap$438.7M
Dividend yield--
Data as of 09/03/2015

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)-4.81%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book3.13

Competitors

 Today’s
change
Today’s
% change
ASNDAscendis Pharma A/S-0.74-3.72%
TRVNTrevena Inc-1.55-13.55%
XNPTXenoport Inc-0.49-6.70%
TBPHTheravance Biopharma...-0.95-6.42%
Data as of 09/03/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
CFO, Secretary, CAO &
General Counsel
David L. Szekeres
Corporate headquarters
San Diego, California

Forecasts

Partner Offers